Prevalence of Vitamin B12 Defi ciency and Clinical Neuropathy with Metformin use in Type 2 Diabetes Mellitus Patients
Cherulil, S.J.; Chafekar, N.D.; Babaliche, P.
Journal of the Association of Physicians of India 68(1): 47
2020
ISSN/ISBN: 0004-5772 PMID: 31979540 Document Number: 18032
There is higher prevalence of Vitamin B12 deficiency and clinical neuropathy with metformin use in Type 2 Diabetes Mellitus patients. It is a preventable cause of neuropathy.
Document emailed within 1 workday
Related Documents
Bhattacharyya, A.; Das, S.L.; Basu, D.A. 2020: Evaluation of Risk Factors of Peripheral Neuropathy in Type 2 Diabetes Mellitus Patients with Special Reference to Vitamin B12 Defi ciency Journal of the Association of Physicians of India 68(1): 52R, P. 2020: The Prevalence of Vitamin B12 Defi ciency in Patients with Hypothyroidism Journal of the Association of Physicians of India 68(1): 44
Pongchaidecha, M.; Srikusalanukul, V.; Chattananon, A.; Tanjariyaporn, S. 2004: Effect of metformin on plasma homocysteine, vitamin B12 and folic acid: a cross-sectional study in patients with type 2 diabetes mellitus Journal of the Medical Association of Thailand 87(7): 780-787
Grant, P.J. 1998: Metformin reduces circulating factor VIi concentrations in patients with type 2 diabetes mellitus Thrombosis and Haemostasis 80(1): 209-210
Ballary, C.; Desai, A. 2003: Efficacy and safety of a combination of metformin and rosiglitaone in patients with type 2 diabetes mellitus--a postmarketing study Journal of the Indian Medical Association 101(2): 113-114; 123
Parry-Strong, A.; Langdana, F.; Haeusler, S.; Weatherall, M.; Krebs, J. 2016: Sublingual vitamin B12 compared to intramuscular injection in patients with type 2 diabetes treated with metformin: a randomised trial New Zealand Medical Journal 129(1436): 67-75
Galicka-Latała, D.; Fedak, D.; Kuźniewski, M.; Kawalec, E.; Solnica, B. 2004: Cardiovascular autonomic neuropathy and nephropathy in patients with type-1 diabetes mellitus Przeglad Lekarski 61(3): 155-158
González-Ortiz, M.; Martínez-Abundis, E. 2004: Efficacy and safety of glimepiride plus metformin in a single presentation, as combined therapy, in patients with type 2 diabetes mellitus and secondary failure to glibenclamide, as monotherapy Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 56(3): 327-333
Ashok, S.; Ramu, M.; Deepa, R.; Mohan, V. 2002: Prevalence of neuropathy in type 2 diabetic patients attending a diabetes centre in South India Journal of the Association of Physicians of India 50: 546-550
Gupta, S.; Sharma, T.K.; Kaushik, G.G.; Shekhawat, V.P.S. 2011: Vitamin E Supplementation May Ameliorate Oxidative Stress in Type 1 Diabetes Mellitus Patients Clinical Laboratory 57(5-6): 379-386
Zhang, J.-p.; Yang, W.-y.; Hong, T.-p.; Yang, J.-k.; Xiao, W.-h.; Gao, H.-w.; Yang, Y. 2007: Efficacy and safety of extended-release metformin in treatment of type 2 diabetes mellitus Zhonghua Yi Xue Za Zhi 87(18): 1238-1240
Centeno Maxzud, M.; Gómez Rasjido, L.; Fregenal, M.; Arias Calafiore, F.; Córdoba Lanus, M.; D'Urso, M.; Luciardi, H.éc. 2016: Prevalence of thyroid dysfunction in patients with type 2 diabetes mellitus Medicina 76(6): 355-358
Frasier, S.D.; Penny, R.; Snyder, R.; Goldstein, I.; Graves, D. 1986: Antithyroid antibodies in Hispanic patients with type I diabetes mellitus. Prevalence and significance American Journal of Diseases of Children 140(12): 1278-1280
Maciejewska, A.; Jaskółowska, A.; Kwaśniewska, J. 2004: Fungi in patients with diabetes mellitus type 2: prevalence, species of isolated strains Wiadomosci Parazytologiczne 50(2): 163-170
Jongsareejit, A.; Potisat, S.; Krairittichai, U.; Sattaputh, C.; Arunratanachote, W. 2013: The Thai DMS Diabetes Complications (DD.Comp.) project: prevalence and risk factors of diabetic retinopathy in Thai patients with type 2 diabetes mellitus Journal of the Medical Association of Thailand 96(11): 1476-1482
Krairittichai, U.; Potisat, S.; Jongsareejit, A.; Sattaputh, C. 2011: Prevalence and risk factors of diabetic nephropathy among Thai patients with type 2 diabetes mellitus Journal of the Medical Association of Thailand 94(Suppl 2): S1-S5
Brožová, J.; Čechurová, D.; Lacigová, S. 2016: Metabolic syndrome in patients with diabetes mellitus type 1, prevalence, impact on morbidity and mortality Vnitrni Lekarstvi 62(11 Suppl 4: S8-14
Serhiyenko, V.A. 2015: Effects of omega-3 polyunsaturated fatty acids on the state of insulin resistance, the content of some pro- and antiinflammatory factors in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy Voprosy Pitaniia 84(6): 76-82
Ribera, L.; González-Clemente, Jé.Miguel.; López Alba, T.; Almirall, J. 2002: Fatal lactic acidosis due to metformin in a male with type 2 diabetes mellitus and dehydration. Comments about a patient information leaflet Medicina clinica 119(4): 158
Uzun, N.; Uluduz, D.; Mikla, S.; Aydin, A. 2006: Evaluation of asymptomatic central neuropathy in type i diabetes mellitus Electromyography and Clinical Neurophysiology 46(3): 131-137